Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m
Privately-owned Grünenthal estimates the Nebido brand will add about €100 million to its EBITDA in 2023.
Grünenthal has agreed to acquire testosterone treatment NebidoTM and...
DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement
DoKaSch Temperature Solutions and Japan Airlines (JAL) have signed a new Master Rental Agreement (MRA) for the usage of the temperature- controlled Opticooler as...
ACHEMA 2022 addresses the industry’s key issues digitalisation and sustainability
In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political situation also poses massive...
EMA guidance supports development of new antibiotics
As part of its efforts to support a global approach to the development of new antimicrobial medicines, EMA has published the final revised guideline...
Vienna Airport and Lufthansa Cargo launch pharma cooperation
The Vienna Airport Pharma Handling Center (VPHC) at Vienna Airport now also handles pharma freight for Lufthansa Cargo. As part of a cooperation between...
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
Charles River Laboratories International, Inc. and Valo Health, Inc have launched Logica , an artificial intelligence (AI) powered drug solution that directly translates clients’...
Catalent Expands Nasal Drug Development and Manufacturing Capabilities at Morrisville, North Carolina, Facility
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...